Regulation (EU) 2025/327 of the European Parliament and of the Council of February 11, 2025 on the European Health Data Space ...

Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended expanding the Marketing Authorisation for ...

Learn more about whether Advanced Energy Industries, Inc. or Celestica Inc. is a better investment based on AAII's A+ ...

Learn more about whether Celestica Inc. or TTM Technologies, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Find out the change in Physiotherapy DUBAI, UAE / ACCESS Newswire / March 28, 2025 / Since the immerge of healthcare innovation and technology, there has been significant change that's complementing ...

Download our guide to the digital therapeutics landscape, key providers, and market trends. Discover how digital health solutions can enhance pharmaceutical outcomes.

A European regulatory committee has rejected Eli Lilly’s U.S.-approved Alzheimer’s disease treatment over potentially ...

The EU medicines regulator on Friday rejected Eli Lilly's Alzheimer's drug, saying the treatment's ability to slow cognitive ...

After failing to pass muster with England’s drug reimbursement watchdog earlier this month, Eli Lilly’s Alzheimer’s disease ...

Eli Lilly's Kisunla was approved in the U.S. for Alzheimer's last year, but now advisers to the European Medicines Agency say it shouldn't be approved.

Eli Lilly (LLY) stock in focus as an expert panel of the EU drug regulator declines to endorse its Alzheimer's drug Kisunla.